Quick answer Connect fluid retention with new respiratory compromise during diazoxide therapy.
Why this is correct Pulmonary hypertension has been reported in neonates and infants receiving diazoxide and can improve after discontinuation. New respiratory distress requires prompt medication interruption and evaluation.
Easy analogy or mental picture Use a family-centered medication-safety loop: verify age or pregnancy context, identify the exposure and new cue, prevent further harm, stabilize the client, and confirm the response.
Memory hook Population, indication, dose or route, contraindication, urgent cue, protective action, and reassessment.
NCLEX decision rule Choose the action that protects the maternal, newborn, or pediatric client from the most immediate medication-related harm while preserving authorized treatment.
Why the other choices are wrong Options that normalize a danger sign, substitute an unapproved route or dose, or delay reassessment leave the client exposed to preventable harm.
References
1DailyMed: diazoxide oral suspensionHyperinsulinism treatment, fluid retention, pulmonary hypertension in neonates and infants, respiratory monitoring, and discontinuation if suspected
Maternal, newborn, and pediatric medication safety reviewVerify the client's age or pregnancy stage, indication, weight or laboratory context, route, interacting therapies, contraindications, caregiver teaching, and measurable follow-up.